Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 839

1.

Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.

Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, Ismailogullari S, Turgut N, Erkurt MA, Sari I, Oztekin M, Solmaz M, Eser B, Ersoy AO, Unal A, Cetin M.

Transfus Apher Sci. 2008 Apr;38(2):109-15. doi: 10.1016/j.transci.2007.11.002. Epub 2008 Mar 10.

PMID:
18331814
2.

Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.

Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O.

Transfus Apher Sci. 2013 Jun;48(3):349-52. doi: 10.1016/j.transci.2013.04.015. Epub 2013 Apr 22.

PMID:
23619327
3.

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.

Yücesan C, Arslan O, Arat M, Yücemen N, Ayyildiz E, Ilhan O, Mutluer N.

Transfus Apher Sci. 2007 Feb;36(1):103-7. Epub 2007 Jan 16. Review.

PMID:
17224307
4.

Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.

Chen WH, Yeh JH, Chiu HC.

J Clin Apher. 1999;14(3):126-9.

PMID:
10540367
5.
6.

Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective.

Agreda-Vásquez GP, Espinosa-Poblano I, Sánchez-Guerrero SA, Crespo-Solís E, Cabrera-Vásquez S, López-Salmorán J, Barajas J, Peñaloza-Ramírez P, Tirado-Cárdenas N, Velázquez A.

J Clin Apher. 2008;23(5):163-7. doi: 10.1002/jca.20175.

PMID:
18819155
7.

Neurologic indications for therapeutic plasma exchange: an update.

Gwathmey K, Balogun RA, Burns T.

J Clin Apher. 2011;26(5):261-8. doi: 10.1002/jca.20298. Epub 2011 Sep 13. Review.

PMID:
21915895
8.

Neurologic indications for therapeutic plasma exchange: 2011 update.

Gwathmey K, Balogun RA, Burns T.

J Clin Apher. 2012;27(3):138-45. doi: 10.1002/jca.21219. Epub 2012 Apr 23. Review.

PMID:
22522566
9.

[Plasmapheresis in neurological diseases. Experience in 140 procedures in 47 patients].

Nogales-Gaete J, Valenzuela D, Liendo F, Vidal P, Gil G, Sáez D.

Rev Med Chil. 2004 Mar;132(3):295-8. Spanish.

PMID:
15376565
10.
11.

Evidence-based review of therapeutic plasma exchange in neurological disorders.

Chhibber V, Weinstein R.

Semin Dial. 2012 Mar-Apr;25(2):132-9. doi: 10.1111/j.1525-139X.2011.01023.x. Epub 2012 Jan 25. Review.

PMID:
22277020
12.

Therapeutic plasma exchange in Casablanca.

Tazi I, Merimi F, Majd A, Benchemsi N.

Transfus Apher Sci. 2008 Aug;39(1):45-8. doi: 10.1016/j.transci.2008.05.009. Epub 2008 Jun 25.

PMID:
18583191
13.

Treatment of Guillain-Barré syndrome and CIDP.

van Doorn PA.

J Peripher Nerv Syst. 2005 Jun;10(2):113-27. Review.

PMID:
15958124
14.

Characteristics of 73 patients, 1984-1993, treated by plasma exchange for Guillain-Barre syndrome.

Mahalati K, Dawson RB, Collins JO, Lietman S, Pearlman S, Gulden D.

J Clin Apher. 1997;12(3):116-21.

PMID:
9365863
15.

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.

Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.

Ther Apher Dial. 2004 Jun;8(3):248-53.

PMID:
15154879
16.

Therapeutic plasma exchange in a single center: Ibni Sina experience.

Arslan O, Arat M, Tek I, Ayyildiz E, Ilhan O.

Transfus Apher Sci. 2004 Jun;30(3):181-4.

PMID:
15172620
17.

Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.

Triantafyllou NI, Grapsa EI, Kararizou E, Psimenou E, Lagguranis A, Dimopoulos A.

Ther Apher Dial. 2009 Jun;13(3):174-8. doi: 10.1111/j.1744-9987.2009.00684.x.

PMID:
19527462
18.

Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra.

Burgstaler EA, Pineda AA.

J Clin Apher. 2001;16(2):61-6.

PMID:
11746530
19.

Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.

Seta T, Nagayama H, Katsura K, Hamamoto M, Araki T, Yokochi M, Utsumi K, Katayama Y.

Clin Neurol Neurosurg. 2005 Oct;107(6):491-6.

PMID:
16202823
20.

Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.

Haupt WF, Rosenow F, van der Ven C, Birkmann C.

Ther Apher. 2000 Jun;4(3):195-7. Review.

PMID:
10910018
Items per page

Supplemental Content

Write to the Help Desk